Supernus Pharmaceuticals INC

Experience in developing and commercializing products that treat central nervous system

Based in MD

🤖

AI Overview

With $320K in lobbying spend across 17 quarterly filings, Supernus Pharmaceuticals INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2022 to 2025.

$320K
Total Spend
4
Years Active
1
Firms Hired
10
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2022$60K
2023$80K
2024$100K
2025$80K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Supernus Pharmaceuticals INC disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues

Issues related to Medicare Part B and Part D and issues related to the pharmaceutical industry

issues related to the pharmaceutical industry

issues related to Medicare drug reimbursement

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.